# Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

> **NCT01883817** · PHASE3 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 30 (actual)

## Conditions studied

- Attention Deficit Disorder

## Interventions

- **DRUG:** DHA Omega-3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01883817
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2017-03-03
- **Final completion:** 2017-03-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883817, "Effect of Omega-3 Fatty Acid on Cortical Function in ADHD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01883817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*